Markos Marangos
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antimicrobial Resistance in Staphylococcus 26
- COVID-19 Clinical Research Studies 18
- Antifungal resistance and susceptibility 9
- Epidemiology 52
- Infective Endocarditis Diagnosis and Management 14
- Co-authors
- Fotini Fligou (38 shared papers)Stelios F. Assimakopoulos (36 shared papers)Matthaios Papadimitriou‐Olivgeris (44 shared papers)Evangelos D. Anastassiou (29 shared papers)Iris Spiliopoulou (36 shared papers)Charalambos Gogos (15 shared papers)Myrto Christofidou (22 shared papers)Christina Bartzavali (17 shared papers)
- Journals
- Infection (10 papers)Journal of Medical Microbiology (7 papers)Antibiotics (6 papers)Diagnostic Microbiology and Infectious Disease (6 papers)European Journal of Clinical Microbiology & Infectious Diseases (6 papers)
- Partner nations
- GreeceUnited StatesSwitzerland
In The Last Decade
Markos Marangos
178 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 133
- Molecular Medicine 619
- Applied Microbiology and Biotechnology 229
- Infectious Diseases 775
- Endocrinology 188
- Clinical Biochemistry 195
Countries citing papers authored by Markos Marangos
This map shows the geographic impact of Markos Marangos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markos Marangos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markos Marangos more than expected).
Fields of papers citing papers by Markos Marangos
This network shows the impact of papers produced by Markos Marangos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markos Marangos. The network helps show where Markos Marangos may publish in the future.
Co-authors
The 25 scholars most cited alongside Markos Marangos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 181 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 160 | |
| 2 | 2020 | 93 | |
| 3 | 2012 | 87 | |
| 4 | 2017 | 85 | |
| 5 | 2014 | 79 | |
| 6 | 2013 | 79 | |
| 7 | 2013 | 75 | |
| 8 | 1994 | 57 | |
| 9 | 2017 | 55 | |
| 10 | 2019 | 55 | |
| 11 | 2014 | 54 | |
| 12 | 1995 | 53 | |
| 13 | Infectious complications in patients with lung cancer. | 2013 | 50 |
| 14 | 2010 | 49 | |
| 15 | 2016 | 47 | |
| 16 | Triple combination therapy with high-dose ampicillin/sulbactam, high-dose tigecycline and colistin in the treatment of ventilator-associated pneumonia caused by pan-drug resistant Acinetobacter baumannii: a case series study. | 2019 | 47 |
| 17 | 2004 | 44 | |
| 18 | 2009 | 43 | |
| 19 | 2014 | 42 | |
| 20 | 2014 | 41 |
About Markos Marangos
Markos Marangos is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Pharmacology and Clinical Biochemistry, having authored 181 papers that have together received 3.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (28 papers), Antimicrobial Resistance in Staphylococcus (26 papers), COVID-19 Clinical Research Studies (18 papers), Antibiotics Pharmacokinetics and Efficacy (17 papers), Bacterial Identification and Susceptibility Testing (15 papers), Antibiotic Use and Resistance (14 papers), Infective Endocarditis Diagnosis and Management (14 papers) and Antifungal resistance and susceptibility (9 papers). The work is most often cited by research in Molecular Medicine (619 citations), Applied Microbiology and Biotechnology (229 citations), Infectious Diseases (775 citations), Endocrinology (188 citations) and Clinical Biochemistry (195 citations). Markos Marangos has collaborated with scholars based in Greece, United States and Switzerland. Frequent co-authors include Fotini Fligou, Stelios F. Assimakopoulos, Matthaios Papadimitriou‐Olivgeris, Evangelos D. Anastassiou, Iris Spiliopoulou, Charalambos Gogos, Myrto Christofidou, Christina Bartzavali, Maria Lagadinou and Kriton S. Filos. Their work appears in journals such as Infection, Journal of Medical Microbiology, Antibiotics, Diagnostic Microbiology and Infectious Disease and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.